Betrixaban clinical trials
How each study uses betrixaban is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 23 Jun 2017 · BEVYXXA · NDA 208383 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Portola Pharmaceuticals (8) · Alexion Pharmaceuticals, Inc. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Factor Xa inhibitors source
Studies
Open first, then newest update. How each study uses betrixaban is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Study Evaluating Betrixaban in Pediatric ParticipantsTerminatedPhase 1Alexion Pharmaceuticals, Inc.NCT03346083Written as Betrixaban
- A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal ImpairmentCompletedPhase 1Portola PharmaceuticalsNCT00999336Written as Betrixaban
- A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male VolunteersCompletedPhase 1Portola PharmaceuticalsNCT01765868Written as Betrixaban
- A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban FormulationsCompletedPhase 1Portola PharmaceuticalsNCT02596100Written as Betrixaban
- Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)CompletedPhase 3Portola PharmaceuticalsNCT01583218Written as Betrixaban
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to WarfarinCompletedPhase 2Portola PharmaceuticalsNCT00742859Written as betrixaban
- Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)CompletedPhase 2Portola PharmaceuticalsNCT00375609Written as Betrixaban
- Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial FlutterCompletedPhase 2Portola PharmaceuticalsNCT01229254Written as Betrixaban 60 mg
- The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa AntagonistCompletedPhase 1Portola PharmaceuticalsNCT03397888Written as Betrixaban
Given beside what is tested · 1 — betrixaban is usual care or a partner of the new treatment
Codes
What other systems call betrixaban · ClinicalTrials.gg INT005481
- MeSH (NLM) C543086betrixabanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 74RWP7W0J9BETRIXABANConfirmed FDA, NLM, Wikidata
- RxNorm 1927851Confirmed FDA, Wikidata
- Wikidata Q4898219betrixabanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75154BetrixabanConfirmed FDA, Wikidata
- DrugBank DB12364One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C543086 | betrixaban | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 74RWP7W0J9 | BETRIXABAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1927851 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4898219 | betrixaban | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75154 | Betrixaban | Confirmed FDA, Wikidata |
| DrugBank | DB12364 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.